Silence Therapeutics plc

Ownership Transactions Reported by 8 Insiders

Symbol
SLN on Nasdaq, SLNCF on OTC
Industry
Pharmaceutical Preparations
Location
72 Hammersmith Road, London, United Kingdom

There are no Buy or Sell transactions made by insiders since 4/22/2024

Silence Therapeutics plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Michael H. Davidson Director Jan 2, 2025
James Ede-Golightly Director Jan 2, 2025
Steven J. Romano EVP and Chief R&D Officer Jan 2, 2025
Iain Ross Director Jan 2, 2025
Craig A. Tooman President and CEO, Director Jan 2, 2025
David Lemus Director Jan 2, 2025
Rhonda Hellums Chief Financial Officer Jan 2, 2025
Griffiths Richard Ian 10%+ Owner Apr 10, 2025

Recent Insider Transactions by Companies or Individuals for Silence Therapeutics plc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.